தேசிய மருத்துவ ஆராய்ச்சி சபை News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from தேசிய மருத்துவ ஆராய்ச்சி சபை. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In தேசிய மருத்துவ ஆராய்ச்சி சபை Today - Breaking & Trending Today

Singapore survey finds elderly unreceptive to digital health services


Photo by d3sign/Getty Images
A study by the Singapore Eye Research Institute found low acceptance of digital health services among the elderly.
Supported by the National Medical Research Council, the SERI study aimed to determine COVID-19-related awareness, knowledge, impact and preparedness among elderly Asians. In the process, the study also evaluated acceptance toward digital health services amid the pandemic.
WHAT IT’S ABOUT
Held during Singapore’s lockdown period from 7 April till 1 June 2020, participants comprised 523 citizens from Singapore s three major ethnic groups – Chinese, Indians, and Malays.
Multivariable logistic regression models were performed to evaluate the associations between demographic, socio-economic, lifestyle, and systemic factors, with COVID-19 awareness, knowledge, preparedness, well-being and digital health service acceptance. ....

Singapore Eye Research Institute , National Medical Research Council , Infocomm Media Development Authority , Senior Go Digital , சிங்கப்பூர் கண் ஆராய்ச்சி நிறுவனம் , தேசிய மருத்துவ ஆராய்ச்சி சபை , இன்பொக்கோம்ம் மீடியா வளர்ச்சி அதிகாரம் , மூத்தவர் போ டிஜிட்டல் ,

Vela Diagnostics Announces Collaboration with the National Cancer Centre of Singapore to Refine Novel Cancer Therapy


Vela Diagnostics Announces Collaboration with the National Cancer Centre of Singapore to Refine Novel Cancer Therapy
USA - English
Share this article
Share this article
SINGAPORE, June 3, 2021 /PRNewswire/ Vela Diagnostics announced a collaboration with the National Cancer Centre of Singapore (NCCS) to develop a molecular diagnostic assay to predict individual patients responses to a cancer therapy called Epidermal Growth Factor Receptor (EGFR) tyrosine kinase inhibitors (TKIs). Being able to predict an individual s response will help clinicians determine if EGFR-TKIs are a suitable therapeutic option for the patient. The partnership between Vela Diagnostics and NCCS aims to refine the therapeutic management of cancer to improve clinical outcomes. ....

Charlie Lee , Gopal Iyer , Head Of Research , National Cancer Centre Of Singapore , Scientist Individual Research Grant , Head Of The Division Medical Sciences , Neck Centre , Division Of Medical Oncology , Singapore Translational Cancer Consortium , Epidemiological Services , National Cancer Centre , Epidermal Growth Factor Receptor , Vela Diagnostics , Nature Medicine , Professor Gopal Iyer , Associate Professor Daniel Tan , Prof Gopal Iyer , Medical Sciences , Senior Consultant , Assoc Prof Daniel Tan , Deputy Head , Clinical Trials , Medical Oncology , Singapore Ministry , National Medical Research Council , Clinician Scientist Individual Research Grant ,